Insiders Trades
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (52 ops.)
Latest filing published 08 Oct 2026 for Relay Therapeutics, Inc., €290k. Read the official filing
Filing timeline
BuySaleThomas Catinazzo
Insider track record
Disclosed buys
0
Disclosed sells
52
Signal history
Thomas Catinazzo: trading record in brief
Thomas Catinazzo (finance chief) discloses dealings in Relay Therapeutics, Inc. to SEC (Form 4). We count 65 filings; the first trade dates from 30 March 2021 and the latest from 6 October 2026.
On the market, this insider has only sold: 52 sales, €2.5M in total. The totals do not cover 4 filings with an undisclosed amount. Besides market trades, the filings include 3 share grants and 10 option exercises. Since January 2026: no purchases and 16 sales on the market.
The record was last updated on 8 October 2026 with an open-market sale (€290k) in Relay Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Thomas Catinazzo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations65 total
17,511 shares@ US$18.58Common StockSEC:0001193125-26-418094:0
206 shares@ US$19.26Common StockSEC:0001193125-26-418094:1
17,717 shares@ US$18.940.0083% mcap14.0% of flowCommon StockSEC:0001193125-26-386464:0
17,717 shares@ US$19.740.0087% mcap14.7% of flowCommon StockSEC:0001193125-26-355493:0
1,459 shares@ US$18.610.0007% mcap1.2% of flowCommon StockSEC:0001193125-26-326144:0
17,717 shares@ US$18.690.0083% mcap14.0% of flowCommon StockSEC:0001193125-26-298679:0
17,717 sharesCommon StockSEC:0001193125-26-281061:0
56,323 sharesCommon StockSEC:0001193125-26-281061:1
56,323 sharesCommon StockSEC:0001193125-26-281061:2
61,563 sharesCommon StockSEC:0001193125-26-281061:3
61,563 sharesCommon StockSEC:0001193125-26-281061:4
51,560 sharesCommon StockSEC:0001193125-26-281061:5
51,560 sharesCommon StockSEC:0001193125-26-281061:6
17,717 shares@ US$12.860.0050% mcap31.6% of flowCommon StockSEC:0001193125-26-224545:0
972 shares@ US$14.790.0003% mcap0.6% of flowCommon StockSEC:0001193125-26-197419:0
17,717 shares@ US$13.019.6% of flowCommon StockSEC:0001193125-26-150044:0
1,800 shares@ US$5.220.4% of flowCommon StockSEC:0001193125-26-150044:1
1,800 shares@ US$15.001.1% of flowCommon StockSEC:0001193125-26-150044:2
17,717 shares@ US$10.067.5% of flowCommon StockSEC:0001193125-26-102270:0
13,820 shares@ US$7.624.3% of flowCommon StockSEC:0001193125-26-029403:0
21,664 shares@ US$7.296.6% of flowCommon StockSEC:0001193125-25-258574:0
1,701 shares@ US$3.740.3% of flowCommon StockSEC:0000950170-25-100366:0
1,709 shares@ US$3.170.2% of flowCommon StockSEC:0000950170-25-061366:0
981 shares@ US$3.170.1% of flowCommon StockSEC:0000950170-25-061366:1
3,558 shares@ US$3.230.5% of flowCommon StockSEC:0000950170-25-061366:2
25 of 65 declarations
